Patent details
EP3993796 Title: COMBINATION FOR THE TREATMENT OF INFECTIONS CAUSED BY MYCOPLASMA GENITALIUM
Basic Information
- Publication number:
- EP3993796
- PCT Application Number:
- EP2020068754
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP207395856
- PCT Publication Number:
- WO2021004910
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMBINATION FOR THE TREATMENT OF INFECTIONS CAUSED BY MYCOPLASMA GENITALIUM
- French Title of Invention:
- COMBINAISON POUR LE TRAITEMENT DES INFECTIONS CAUSÉES PAR MYCOPLASMA GENITALIUM
- German Title of Invention:
- KOMBINATION ZUR BEHANDLUNG VON INFEKTIONEN DURCH MYCOPLASMA GENITALIUM
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 15/03/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 22/03/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 21/02/2024
- Unitary Effect Registration Date:
- 22/03/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 03/07/2020
- Grant date:
- 21/02/2024
- EP Publication Date:
- 11/05/2022
- PCT Publication Date:
- 14/01/2021
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 21/02/2024
- EP B1 Publication Date:
- 21/02/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 03/07/2040
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 14/02/2024
- Name:
- GlaxoSmithKline Intellectual Property Development Limited
- Address:
- GSK Medicines Research Centre Gunnels Wood Road, Stevenage SG1 2NY, United Kingdom (GB)
Inventor
- Name:
- SCANGARELLA-OMAN, Nicole
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201962870990 P
- Priority Date:
- 05/07/2019
- Priority Country:
- United States (US)
2
- Priority Number:
- 202062985465 P
- Priority Date:
- 05/03/2020
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/4985; A61K 31/65; A61P 13/00; A61P 15/00; A61P 31/04;
Publication
European Patent Bulletin
1
- Issue number:
- 202408
- Publication date:
- 21/02/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202417
- Publication date:
- 24/04/2024
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202417
- Publication date:
- 24/04/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|